Related Experiment Video
Updated: May 3, 2026

Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies
Published on: August 29, 2017
Predictability of antigenic evolution for H3N2 human influenza A virus
1Graduate School of Natural Sciences, Nagoya City University.
Predicting influenza A virus evolution is crucial for vaccine development. A new theoretical method estimates antigenic distance, suggesting natural selection drives H3N2 evolution.
Area of Science:
- Virology
- Immunology
- Computational Biology
Background:
- Influenza A virus poses a significant public health risk due to rapid antigenic evolution.
- Effective vaccine development requires accurate prediction of viral antigenic drift.
- Existing empirical methods lack insight into mutation effects and evolutionary mechanisms.
Purpose of the Study:
- To develop a theoretical method for predicting H3N2 human influenza A virus antigenic evolution.
- To estimate antigenic distance by evaluating de novo mutations.
- To understand the mechanisms driving influenza A virus antigenic evolution.
Main Methods:
- Developed a theoretical model to predict antigenic evolution of H3N2 influenza A virus.
- Estimated antigenic distance using hemagglutination inhibition (HI) titers.
- Incorporated amino acid properties (volume, isoelectric point, accessibility) and locations (receptor-binding sites, glycosylation sites) in hemagglutinin 1 (HA1) into antigenic models.
Main Results:
- The best theoretical model showed relatively low prediction accuracy for dominant strains.
- Identified a tendency for amino acid sites with greater potential impact on antigenicity to evolve.
- Observed a higher likelihood of amino acid changes with larger potential effects occurring.
Conclusions:
- Natural selection may play a role in enhancing the antigenic evolution of H3N2 influenza A virus.
- The theoretical model provides insights into potential drivers of viral antigenic change.
- Further refinement of predictive models is needed for improved vaccine strain selection.
More Related Videos
12:09Measuring Influenza Neutralizing Antibody Responses to AH3N2 Viruses in Human Sera by Microneutralization Assays Using MDCK-SIAT1 Cells
Published on: November 22, 2017
06:34An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers
Published on: December 1, 2017
Related Concept Videos
Viral Mutations
Influenza
Infectious Diseases and Their Occurrence
Viral Recombination